ProShare Advisors
OPTR

ProShare Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

ProShare Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-47,950
Closed -$604K – 2460
2013
Q3 		$604K Buy
47,950
+8,033
+20% +$106K 0.01% 1304
2013
Q2 		$578K Buy
+39,917
New +$581K 0.01% 1216

ProShare Advisors's OPTR Position: Q4 2013 in Review

ProShare Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 47,950 shares — an estimated $604K sold.

ProShare Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $604K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • ProShare Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • ProShare Advisors sold 47,950 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $604K.
  • ProShare Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • ProShare Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $604K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on ProShare Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.